Trial intelligence / Profile preview

MB-6 plus FOLFOX4 in metastatic colorectal cancer

NCT01047475Phase 2Completed

Sponsor
Microbio Co., Ltd.
Start
Oct 2009
Primary completion
Apr 2011
Countries
1
01

Overview

A Phase 2 trial of MB-6 in metastatic colorectal cancer (mCRC), sponsored by Microbio Co., Ltd.. Started Oct 2009; status: completed.

02

Drugs

MB-6
03

Conditions

metastatic colorectal cancer (mCRC)

Beyond the preview

Go deeper on NCT01047475.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01047475.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call